IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development Programmes

Contributed by: Business Wire

Tags

Technology
Biotechnology
Health
Finance
Pharmaceutical
Professional Services
Artificial Intelligence
Research
Medical Devices
Software
Genetics
Science
Data Management
Clinical Trials
transplant-related clinical development

More Like This

Business Wire logo

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

PR Newswire associated0

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling Initiative

PR Newswire associated0

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response

HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data